The aim of this study was to optimize a radiolabeling method using cationic processed Ga-68 eluates from a SnO2-based 68Ge/68Ga generator, followed by the development of DOTA-Tyr3-Thre8-octreotide (DOTATATE) kits.
Diluted generator eluates were adsorbed on a SCX resin and desorbed with acidified 5 M NaCl solution. Optimized labeling conditions were determined by variation of pH, using 35 μg DOTATATE and sodium acetate buffer. DOTATATE kits were developed based on optimized radiolabeling conditions, were labeled, and evaluated.
Optimized labeling conditions resulted in a radiolabeling efficiency of around 99 % and radiochemical yield of almost 85 %. Different kit preparation methods did not significantly influence the radiolabeling results. Kits were found to be stable over 3 months.
A labeling method using SCX-processed Ga-68 eluates was optimized. DOTATATE kits specifically for these SCX-processed Ga-68 eluates were successfully formulated. A post-labeling Sep-Pak C18 purification should be optional.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Fani M, André JP, Maecke HR (2008) 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging 3:67–77
Maecke HR, Hofmann M, Haberkorn U (2005) 68Ga-labeled peptides in tumor imaging. J Nucl Med 46:172S–178S
Breeman WAP, Verbruggen AM (2007) The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 34:978–981
Roesch F (2012) Maturation of a key resource—the germanium-68/gallium-68 generator: development and new insights. Curr Radiopharm 5:202–211
Breeman WAP, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging 32:478–485
de Blois E, Sze Chan H, Naidoo C, Prince D, Krenning EP, Breeman WAP (2011) Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides. Appl Radiat Isot 69:308–315
Rossouw DD, Breeman WAP (2012) Scaled-up radiolabelling of DOTATATE with 68Ga eluted from a SnO2-based 68Ge/68Ga generator. Appl Radiat Isot 70:171–175
Roesch F, Zhernosekov K, Filosofov D et al (2006) Processing of Ge-68/Ga-68 generator eluates for labeling of biomolecules via bifunctional chelators. J Nucl Med 47:162P
Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rosch F (2007) Processing of generator-produced 68Ga for medical application. J Nucl Med 48:1741–1748
Asti M, De Pietri G, Fraternali A et al (2008) Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC. Nucl Med Biol 35:721–724
Ocak M, Antretter M, Knopp R, Kunkel F, Petrik M, Bergisadi N, Decristoforo C (2010) Full automation of 68Ga labelling of DOTA-peptides including cation exchange prepurification. Appl Radiat Isot 68:297–302
Mueller D, Klette I, Baum RP, Gottschaldt M, Schultz MK, Breeman WAP (2012) Simplified NaCl based 68Ga concentration and labeling procedure for rapid synthesis of 68Ga radiopharmaceuticals in high radiochemical purity. Bioconjug Chem 23:1712–1717
Schultz MK, Mueller D, Baum RP, Leonard Watkins G, Breeman WAP (2013) A new automated NaCl based robust method for routine production of gallium-68 labeled peptides. Appl Radiat Isot 76:46–54
Martin R, Jüttler S, Müller M, Wester HJ (2014) Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2. Nucl Med Biol 41:84–89
Seemann J, Eppard E, Waldron BP, Ross TL, Roesch F (2015) Cation exchange-based post-processing of 68Ga eluate: a comparison of three solvent systems for labelling of DOTATOC, NO2APBP and DATAm. Appl Radiat Isot 98:54–59
Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Development of single vial kits for preparation of 68Ga-labelled peptides for PET imaging of neuroendocrine tumours. Mol Imaging Biol 16:550–557
Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Single vial kit formulation for preparation of PET radiopharmaceutical: 68Ga-DOTA-TOC. J Radioanal Nucl Chem 302:1253–1258
Das T, Bhadwal M, Sarma HD, Banerjee S (2014) Formulation and radiochemical evaluation of a freeze-dried mixed peptide kit for the preparation of 68Ga-labeled peptides for PET imaging of somatostatin receptor positive neuroendocrine cancers. J Radioanal Nucl Chem 302:1259–1264
Asti M, Iori M, Capponi PC, Rubagotti S, Fraternali A, Versari A (2015) Development of a simple kit-based method for preparation of pharmaceutical-grade 68Ga-DOTATOC. Nucl Med Commun 36(5):502–510
Mukherjee A, Korde A, Sarma HD, Samuel G (2014) Single vial formulation for theranostic radiopharmaceutical preparation. J Radioanal Nucl Chem 302:889–894
Prince D, Rossouw D, Davids C, Rubow S (2017) Development and evaluation of user-friendly single vial DOTA-peptide kit formulations, specifically designed for radiolabelling with 68Ga from a tin dioxide 68Ge/68Ga generator. Mol Imaging Biol 19:817–824
Hofmann M, Maecke H, Börner AR, Weckesser E, Schöffski P, Oei M, Schumacher J, Henze M, Heppeler A, Meyer G, Knapp W (2001) Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 28:1751–1757
Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, Mäcke HR, Hofmann M, Debus J, Haberkorn U (2001) PET imaging of somatostatin receptors using [68Ga]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med 42:1053–1056
Decristoforo C, Knopp R, von Guggenberg E, Rupprich M, Dreger T, Hess A, Virgolini I, Haubner R (2007) A fully automated synthesis for the preparation of 68Ga-labelled peptides. Nucl Med Commun 28:870–875
Velikyan I, Beyer GJ, Långström B (2004) Microwave-supported preparation of 68Ga bioconjugates with high specific radioactivity. Bioconjug Chem 15:554–560
Velikyan I, Sundin A, Eriksson B, Lundqvist H, Sörensen J, Bergström M, Långström B (2010) In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours—impact of peptide mass. Nucl Med Biol 37:265–275
Velikyan I, Xu H, Nair M, Hall H (2012) Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE. Nucl Med Biol 39:628–639
Meyer GJ, Hofmann M, Kühn J et al (2003) 68Ga-labelled DOTA-derivatised peptide ligands. J Labelled Comp Radiopharm 46:S273
Conflict of Interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Prince, D., Rossouw, D. & Rubow, S. Optimization of a Labeling and Kit Preparation Method for Ga-68 Labeled DOTATATE, Using Cation Exchange Resin Purified Ga-68 Eluates Obtained from a Tin Dioxide 68Ge/68Ga Generator. Mol Imaging Biol 20, 1008–1014 (2018). https://doi.org/10.1007/s11307-018-1195-x
- Ga-68 eluate
- SnO2-based 68Ge/68Ga generator
- Radiolabeling efficiency
- Radiochemical yields
- Cation exchange resin